Skandinaviska Enskilda Banken (SEB)
IDYA icon

Skandinaviska Enskilda Banken (SEB)’s IDEAYA Biosciences IDYA Stock Holding History

Skandinaviska Enskilda Banken (SEB)’s Portfolio IDYA Stock Details IDYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-32,544
Closed -$684K – 839
2025
Q2 		$684K Hold
32,544
– – ﹤0.01% 683
2025
Q1 		$533K Hold
32,544
– – ﹤0.01% 683
2024
Q4 		$811K Hold
32,544
– – ﹤0.01% 678
2024
Q3 		$1.03M Hold
32,544
– – ﹤0.01% 666
2024
Q2 		$1.14M Hold
32,544
– – 0.01% 628
2024
Q1 		$1.43M Buy
32,544
+12,933
+66% +$556K 0.01% 626
2023
Q4 		$698K Hold
19,611
– – ﹤0.01% 738
2023
Q3 		$529K Hold
19,611
– – ﹤0.01% 759
2023
Q2 		$461K Buy
+19,611
New +$403K ﹤0.01% 800

Other funds holding IDYA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Skandinaviska Enskilda Banken (SEB)'s IDYA Position: Q3 2025 in Review

Skandinaviska Enskilda Banken (SEB) sold out of IDEAYA Biosciences (IDYA) in Q3 2025, closing a stake of 32,544 shares — an estimated $684K sold.

Skandinaviska Enskilda Banken (SEB) first reported a position in IDYA in Q2 2023 and held it in 9 quarters. The position peaked at $1.43M in Q1 2024. 224 funds tracked by Wall St. Rank hold IDYA as of Q3 2025.

  • Skandinaviska Enskilda Banken (SEB) reported no remaining IDEAYA Biosciences position as of Q3 2025 after selling out during the quarter.
  • Skandinaviska Enskilda Banken (SEB) sold 32,544 IDEAYA Biosciences shares in Q3 2025, an estimated $684K.
  • Skandinaviska Enskilda Banken (SEB) first reported a position in IDEAYA Biosciences in Q2 2023 and held it in 9 quarters.
  • Skandinaviska Enskilda Banken (SEB)'s IDEAYA Biosciences position peaked at $1.43M in Q1 2024.
  • 224 funds tracked by Wall St. Rank held IDEAYA Biosciences as of Q3 2025.

Based on Skandinaviska Enskilda Banken (SEB)'s 13F filing for Q3 2025, filed 7 Nov 2025.